Study suggests reducing the expression of the methyl-CpG-binding domain 2 (MBD2) protein on macrophages could be a viable therapeutic strategy for lung fibrosis.
An analysis of lung tissue samples from patients with various types of pulmonary fibrosis (PF), including cases caused by COVID-19, has identified a promising target – methyl-CpG-binding domain 2 (MBD2), a protein found in macrophages.
Source:https://www.drugtargetreview.com/news/77995/novel-target-mbd2-for-pulmonary-fibrosis-identified-using-tissue-from-covid-19-patients/